|
Name
|
Degree
|
Year
|
Thesis Title
|
Present Employer/Postition
|
| Atul Kumar |
PhD |
2007 |
Impact of surgery and hemorrhagic shock on the pharmacokinetics of cytochrome P450 drug probes
|
University of Minnesota |
| Vikas Kumar |
PhD |
2007 |
Pharmacogenetics of CYP2C9 inhibition |
Pfizer, Inc |
| Wonkyung Byon |
PhD |
2007 |
Population pharmacometric analyses in HIV-infected adults and children: application to zidovudine, lamivudine, indinavir, and efavirenz
|
Pfizer, Inc |
| Lian Wei |
MS |
2006 |
The effect of CYP2C9 genetic polymorphism on reaction coupling and uncoupling |
Vertex, Inc. Cambridge, MA |
| Pam Clemens |
PhD |
2006 |
Alternate routes of Antiepileptic drug administration: A clinical study of rectally administered Oxcarbazepine suspension |
Bristol-Myers Squibb, Clinical Scientist |
| Jae Eun Ahn |
PhD |
2006 |
Pharmacometric characterization of antiepileptic drugs in the elderly |
GloboMax Hanover, MD |
|
Kathleen Green
|
MS
|
2005
|
Mycophenolate Mofetil Pharmacology and Bioavailability in Hematopoietic Cell Transplantation for Malignant Diseases
|
University of Minnesota Medical Center, Fairview Pharmacy
|
|
Matthew Hummel
|
PhD
|
2004
|
Assessment of Multiple Substrate Bending in CYP2C9
|
Mylan Laboratories
|
|
Nitin Kaila
|
PhD
|
2004
|
Pharmacometric issues in modeling and simulation: Metoprolol population pharmacokinetics and pharmacodynamics in healthy subjects
|
Novartis
New Jersey
|
|
Juki Ng
|
PhD
|
2004
|
Cyclophosphamide pharmacogenetics in breast cancer patients
|
Abbott Laboratories, Senior Research Pharmacokineticist
|
Return to: College of Pharmacy : Academic Health Center : myU : U of M Home
